EGFR

CAT # Magaca Alaabta Sharaxaada
CPD100230 JBJ-04-125-02 R-isomer
CPD3232 NTN21277 NTN21277, oo sidoo kale loo yaqaan Gefitinib-based PROTAC 3 waa VHL-qorista PROTAC taas oo keenta hoos u dhaca EGFR iyo EGFR mutants oo leh DC50 ee 11.7 nM iyo 22.3 nM ee unugyada HCC827 (Exon 19 del) iyo unugga H3258R (L).
CPDB3615 Nazartinib; EGF816; NVS-816 Nazartinib, oo sidoo kale loo yaqaan EGF816 iyo NVS-816, waa af laga heli karo, aan laga noqon karin, jiilka saddexaad, mutant-doortay korriinka koritaanka epidermal (EGFR), oo leh firfircoonida antineoplastic.
CPDB0934 EAI-045 EAI045 waa mid awood leh oo doorta EGFR horjooge. EAI045 waxay beegsataa doorsoon mutants EGFR u adkaysta daawada laakiin waxay u tudhaysaa soo dhawaynta nooca duurjoogta ah. EAI045 waxay joojisaa L858R/T790M-mutant EGFR oo leh awood hoose oo nanomolar ah oo ku jirta qiimaynta biochemical.
CPDB0101 Poziotib Daawooyinka ay ku jiraan poziotinib ayaa lagu hayaa baadhitaano tijaaboyin caafimaad oo loogu talagalay daawaynta EGFR-mutant adenocarcinoma sambabada.
CPDB0137 Osimertinib Mesylate Osimertinib, oo sidoo kale loo yaqaan mereletinib iyo AZD-9291, waa jiilka saddexaad ee EGFR inhibitor, wuxuu muujiyay ballan-qaadka daraasadaha saxda ah wuxuuna rajo ka qabaa bukaannada qaba kansarka sambabada sare kuwaas oo u adkeysanaya inhibitors EGFR ee jira.
oo

Nala Soo Xidhiidh

Weydiin

Wararkii Ugu Danbeeyay

  • 7-da Isbeddel ee ugu Sarreysa ee Cilmi-baarista Dawooyinka 2018

    7-da Isbeddel ee ugu Sarreysa Cilmi-baarista Dawooyinka Waxaan...

    Iyadoo lagu jiro cadaadis sii kordhaya si loogu tartamo jawi dhaqaale iyo teknoloji oo adag, shirkadaha dawooyinka iyo bayoolojiga waa inay si joogto ah u cusbooneysiiyaan barnaamijyadooda R&D si ay horay ugu sii socdaan ...

  • ARS-1620: Horjooge cusub oo rajo leh oo loogu talagalay kansarka-KRAS-mutant

    ARS-1620: Horjooge cusub oo rajo leh oo loogu talagalay K...

    Sida laga soo xigtay cilmi-baaris lagu daabacay Cell, cilmi-baarayaashu waxay sameeyeen xannibaado gaar ah oo loogu talagalay KRASG12C oo loo yaqaan ARS-1602 taas oo keentay dib u noqoshada buro ee jiirarka. "Daraasaddani waxay ku siinaysaa caddayn vivo ah in KRAS mutant uu noqon karo ...

  • AstraZeneca waxay heshaa kor u qaadida sharciyeynta ee daawooyinka kansarka

    AstraZeneca waxay heshay kor u qaadida sharciyeynta ee...

    AstraZeneca waxay heshay labanlaab kor u qaadis ah faylalka Oncology Talaadadii, ka dib markii sharciyeeyayaasha Mareykanka iyo Yurub ay aqbaleen soo gudbinta sharciyeynta dawooyinkeeda, tallaabada ugu horreysa ee lagu guuleysto oggolaanshaha daawooyinkan. ...

WhatsApp Online chat!